Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions.
Standard
Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions. / de La Taille, Alexandre; Irani, Jacques; Graefen, Markus; Chun, Felix; de Reijke, Theo; Kil, Paul; Gontero, Paolo; Mottaz, Alain; Haese, Alexander.
in: J UROLOGY, Jahrgang 185, Nr. 6, 6, 2011, S. 2119-2125.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions.
AU - de La Taille, Alexandre
AU - Irani, Jacques
AU - Graefen, Markus
AU - Chun, Felix
AU - de Reijke, Theo
AU - Kil, Paul
AU - Gontero, Paolo
AU - Mottaz, Alain
AU - Haese, Alexander
PY - 2011
Y1 - 2011
N2 - We evaluated the clinical utility of the PCA3 assay in guiding initial biopsy decisions in prostate cancer.
AB - We evaluated the clinical utility of the PCA3 assay in guiding initial biopsy decisions in prostate cancer.
KW - Biopsy
KW - Humans
KW - Male
KW - Aged
KW - Middle Aged
KW - Multivariate Analysis
KW - Prospective Studies
KW - Antigens, Neoplasm/urine
KW - Prostate/pathology
KW - Prostatic Neoplasms/pathology/urine
KW - Biopsy
KW - Humans
KW - Male
KW - Aged
KW - Middle Aged
KW - Multivariate Analysis
KW - Prospective Studies
KW - Antigens, Neoplasm/urine
KW - Prostate/pathology
KW - Prostatic Neoplasms/pathology/urine
M3 - SCORING: Journal article
VL - 185
SP - 2119
EP - 2125
JO - J UROLOGY
JF - J UROLOGY
SN - 0022-5347
IS - 6
M1 - 6
ER -